KIF18A has been suggested to promote proliferation, invasion, and metastasis of HCC cells by activating cell cycle signaling pathway and the Akt and MMP-7/MMP-9-related signaling pathways (Luo et al., 2018). Here, AKT1 is linked to hepatocellular carcinoma.